ArticleInternational journal of clinical and experimental pathology2018
Long non-coding RNA taurine-upregulated gene 1 promotes cells proliferation, migration and invasion while represses apoptosis, and upregulates AURKA expression in hepatocellular carcinoma.
Article in International journal of clinical and experimental pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 8 citations in OpenAlex.
- Unveiling Berberine's Therapeutic Mechanisms Against Hepatocellular Carcinoma via Integrated Computational Biology and Machine Learning Approaches: AURKA and CDK1 as Principal Targets.International journal of molecular sciences · 2025Article
- Deciphering the role ofWorld journal of hepatology · 2025Review
- The ncRNA-AURKA Interaction in Hepatocellular Carcinoma: Insights into Oncogenic Pathways, Therapeutic Opportunities, and Future Challenges.Life (Basel, Switzerland) · 2024Review
- Long non-coding RNABrain communications · 2024Article
- Role of long noncoding RNA taurine-upregulated gene 1 in cancers.Molecular medicine (Cambridge, Mass.) · 2021Review
- AURKB as a Promising Prognostic Biomarker in Hepatocellular Carcinoma.Evolutionary bioinformatics online · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to assess the effect of long non-coding RNA (lncRNA) taurine-upregulated gene 1 (TUG1) on cells proliferation, migration, invasion and apoptosis of hepatocellular carcinoma (HCC) cells. LncRNA TUG1 expression was detected in HCC cell lines (SMMC7721, HepG2 and BEL-7402 cells) and normal liver cells (L-02 cells) by qPCR assay. After the transfection of blank mimic, lncRNA TUG1 mimic, blank inhibitor and lncRNA TUG1 inhibitor plasmids into SMMC7721 cells, CKK8, wound-healing, matrigel assay, AV/PI, qPCR assay and western blot assays were performed to detect cells proliferation, migration, invasion, apoptosis, RNA expression and protein expression respectively. LncRNA TUG1 expression was increased in SMMC 7721 cells, HepG2 cells and BEL-7402 cells compared to L-02 cells. After transfection of lncRNA TUG1 mimic and inhibitor plasmids, cells proliferation, migration and invasion were observed to be increased in lncRNA TUG1 mimic group compared to blank mimic group (NC1), while were decreased in lncRNA TUG1 inhibitor group compared with blank inhibitor group (NC2). As to cells apoptosis, AV/PI assay disclosed that lncRNA TUG1 mimic suppressed cells apoptosis rate than NC1 while lncRNA TUG1 inhibitor promoted cells apoptosis rate than NC2, apoptosis markers (C-Caspase3 and Bcl) protein expression also supported the regulation of lncRNA TUG1 on cells apoptosis. In addition, lncRNA TUG1 positively regulated the protein and mRNA expressions of AURKA, but not SERPINE1 or BRAF. In conclusion, lncRNA TUG1 promotes cells proliferation, migration and invasion while represses apoptosis, and upregulates AURKA expression in HCC cells.
Indexed as
Identifiers
31949695PMC6962875W3028080668What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.